Training scientists to improve treatments for children's lung blood vessel diseases
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease
This study is all about helping kids with lung and heart problems by training new doctors to find better ways to treat their conditions through hands-on research and teamwork.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10918094 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding and treatment of pediatric pulmonary vascular disease (PVD), which affects children with various heart and lung conditions. It aims to train a new generation of physician-scientists through a two-year post-doctoral program that fosters interdisciplinary collaboration among experts in pediatrics. By bridging gaps in knowledge and expertise, the program seeks to develop innovative treatment strategies for these complex disorders. Participants will engage in both laboratory and clinical research to advance the field of pediatric PVD.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with pulmonary vascular disease or related conditions.
Not a fit: Patients with pulmonary vascular diseases that are not amenable to current research methodologies may not benefit from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and outcomes for children suffering from pulmonary vascular diseases.
How similar studies have performed: Previous interdisciplinary training programs have shown promise in advancing research and treatment in other pediatric conditions, suggesting potential success for this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Fineman, Jeffrey R — University of California, San Francisco
- Study coordinator: Fineman, Jeffrey R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.